Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

simone ribero

University of Turin

Italy

Research Interests

Explore related searches

Professors in Italy

Articles (49)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (28)

Luca Potestio

University of Naples Federico II

ITALY

View details

Maria Antonietta Pizzichetta

Associate Professor of Dermatology

Università degli Studi di Torino

ITALY

View details

Giampiero Girolomoni

ITALY

View details

Sebastian Podlipnik

Hospital Clínic de Barcelona

SPAIN

View details

Claudio Bonifati

Istituto Dermatologico San Gallicano

ITALY

View details

mariateresa rossi

University of Brescia

ITALY

View details

G. Roccuzzo

Università degli Studi di Torino

ITALY

View details

francois rosset

University of Turin

ITALY

View details

Steven Nistico

Full Professor

Sapienza University of Rome

ITALY

View details

Andrea Carugno

Assistant Professor (Researcher)

University of Insubria

ITALY

View details

Luca Mastorino

Assistan Professor

University of Turin

ITALY

View details

Barbara Pasini

Associate Professor of Medical Genetics

Università degli Studi di Torino

ITALY

View details

jose-manuel carrascosa

head of department, associated professor

Hospital Universitari Germans Trias i Pujol

SPAIN

View details

Giuseppe Gallo

Università degli Studi di Torino

ITALY

View details

Paolo Del Fiore

Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico

ITALY

View details

Cataldo Patruno

Professor

University of Molise

ITALY

View details

Emanuele Trovato

University of Siena

ITALY

View details

Francesco Giuseppe DE ROSA

Associate Professor, Infectious Diseases

University of Turin

ITALY

View details

Luca Bettolini

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

ITALY

View details

P. Quaglino

ITALY

View details

Emi Dika

Docenti di ruolo di IIa fascia

University of Bologna

ITALY

View details

Mario Vaccaro

University of Messina

ITALY

View details

ilaria mattavelli

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Anna Balato

ITALY

View details

Maddalena Napolitano

University of Naples Federico II

ITALY

View details

Umberto Santaniello

University of Turin

ITALY

View details

E. Nagore

Profesor Asociado

Universidad Católica de Valencia San Vicente Mártir Facultad de Medicina Facultad de Medicina y Odontología

SPAIN

View details

Francesco Borgia

University of Messina

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

simone ribero

Research Interests

Explore related searches

Articles (49)

Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study

Association Between pTERT Promoter Mutation Subtypes and Survival Outcomes in BRAF‐Mutant Metastatic Melanoma Treated With BRAF/MEK Inhibitors: An Exploratory Study

Beyond the Kidney and Lung: Cutaneous and Mucosal Clues to Human Hantavirus Disease

Reflectance Confocal Microscopy Features of Nevoid Melanoma: Case Report and Literature Review

Dynamic Nail‐Bed Phenotyping in Onycholysis: Diagnostic Accuracy Remains Untested

JAK Inhibitors in Psoriatic–Atopic Dermatitis Overlap: A Four‑Case Series

Dissecting Cellulitis and Hidradenitis Suppurativa: Two Diseases or One Follicular‐Occlusion Spectrum?

Real-World Effectiveness of Secukinumab in Congenital Ichthyoses: A Retrospective Monocentric Case Series

Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real‐World Study

A Real‐Life, Multicenter, Retrospective Study on Epidemiological and Clinical Features of Patients With Hidradenitis Suppurativa and Concomitant Down Syndrome

The BEARD Score: A Practical Tool to Assess Beard Involvement in Alopecia Areata

Real-world effectiveness of a topical dihydroavenanthramide D formulation for chronic pruritus: A multicenter clinical study with molecular evidence of pruritogenic pathway modulation

A Zosteriform Papular Cutaneous Eruption

Early On‐Treatment Change in SALT as a Pragmatic Predictor of Ritlecitinib Response in Moderate‐To‐Severe Alopecia Areata: A Real‐World Cohort Study

The Aging Skin–Psoriasis Interface: Could Cellular Senescence and Immunosenescence Slow Therapeutic Response?

When IL-17 Blockade Backfires: Retropharyngeal Granuloma and Petrous Bone Osteonecrosis in a Patient with Psoriasis

Pharmacomicrobiomics in Psoriasis: Microbiome–Drug Interactions Across Systemic Treatments

Dermatologic Perspectives on Primary Cutaneous Lymphomas: Clinicopathologic Spectrum, Molecular Insights, and Evolving Treatment Paradigms

Dermoscopic Features of Solitary Leukemia Cutis in a Patient with Chronic Lymphocytic Leukemia

Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study

Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study

Hormonal Therapies in Cosmetic Dermatology: Mechanisms, Clinical Applications, and Future Perspectives

Monoclonal Antibodies and Small-Molecule Therapies for Lichen Planus: Targeted Immunomodulation and Emerging Evidence

The Epidemiology of Syphilis Worldwide in the Last Decade

Melanoma Clues Beyond Dermoscopic Patterns: Lesion Orientation to Langer’s Lines as a Predictor on the Trunk

Dermoscopy of Melanoma According to Age Groups: A Retrospective Monocentric Study on 285 Patients

Cosmeceuticals for Anti-Aging: Mechanisms, Clinical Evidence, and Regulatory Insights—A Comprehensive Review

Cutaneous and Lymphangitic Infection Caused by <i>Purpureocillium lilacinum</i> in Immunocompromised Patients: A Case Report with a Narrative Review of the Literature

Can't Judge a Book by Its Cover: An Unusual Case of Orbital Swelling

Head–neck melanoma: Clinical, histopathological and prognostic features of an Italian multicentric study

Treatment Patterns and Outcomes of Stage III Melanoma Patients with Positive Sentinel Lymph Node Biopsy: A Real-Life Experience

Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review

Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma

Safety of dupilumab in patients with cancer

Anti‐IL17 Secukinumab in hidradenitis suppurativa: A long‐term drug survival analysis

Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience

More than one shade of pink as a marker of early amelanotic/hypomelanotic melanoma

Secondary laryngeal and pulmonary syphilis: A case report

The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma Intergroup

Efficacy of tralokinumab after failure with upadacitinib and dupilumab in a patient affected by atopic dermatitis

‘Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab failure in psoriatic patients’‐response to Yu et al.

Comparison between brodalumab, secukinumab and ixekizumab effectiveness and drug survival: A real‐life experience on 638 patients with psoriasis

Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab failure in psoriatic patients

Exacerbation of acquired perforating dermatosis following SARS‐CoV‐2 vaccination

Mycosis fungoides and Sézary syndrome following dupilumab treatment: experience of two Italian tertiary care centres

Topographical and Chronological Analysis of Thin Cutaneous Melanoma’s Progressions: A Multicentric Study

Phenotypic and Dermoscopic Patterns of Familial Melanocytic Lesions: A Pilot Study in A Third-Level Center

Impact of comorbidities in elderly and frail patients and response to biological therapy in psoriasis

Drug survival, effectiveness and safety of ixekizumab for moderate‐to‐severe psoriasis up to 5 years

Collaborators (28)

Luca Potestio

Maria Antonietta Pizzichetta

Giampiero Girolomoni

Sebastian Podlipnik

Claudio Bonifati

mariateresa rossi

G. Roccuzzo

francois rosset

Steven Nistico

Andrea Carugno

Luca Mastorino

Barbara Pasini

jose-manuel carrascosa

Giuseppe Gallo

Paolo Del Fiore

Cataldo Patruno

Emanuele Trovato

Francesco Giuseppe DE ROSA

Luca Bettolini

P. Quaglino

Emi Dika

Mario Vaccaro

ilaria mattavelli

Anna Balato

Maddalena Napolitano

Umberto Santaniello